Skip to main content

Medically Advised Aspirin Use Lower in 2021 Than 2012 to 2017

Medically reviewed by Carmen Pope, BPharm. Last updated on June 25, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, June 24, 2024 -- Medically advised aspirin use was lower in 2021 than in 2012 to 2017 among older adults, according to a research letter published online June 25 in the Annals of Internal Medicine.

Mohak Gupta, M.D., from the Cleveland Clinic, and colleagues characterized trends in prevalence of aspirin use for CVD prevention among U.S. adults aged 40 years or older using data from the National Health Interview Survey Sample Adult component (2012 to 2019 and 2021). Data were included for 186,425 participants, representing about 150 million adults annually.

The researchers found that 18.5 percent of adults aged 40 years or older reported aspirin use for primary prevention in 2021. Of those aged 60 years or older, 29.7 percent reported primary prevention use in 2021, with 5.2 percent using aspirin without medical advice. From 2012 to 2017, there was a minimal decline in aspirin use for primary prevention, but a larger decrease was seen after 2018, especially among those aged 60 years or older. Compared with 2012 to 2017, in 2021, medically advised aspirin use for primary prevention was lower (19.3 versus 27.6 to 31.2 percent among adults aged 60 to 69 years; 30.6 versus 38.35 to 41.6 percent among those aged 70 years or older).

"Our findings highlight the urgent need for physicians to inquire about aspirin use, including self-use, and engage in risk-benefit discussions to reduce inappropriate use for primary prevention in older adults," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted June 2024

Read this next

Outdoor Light at Night, Air Pollution Linked to Cerebrovascular Disease

TUESDAY, March 26, 2024 -- Outdoor light at night (LAN) and air pollution are associated with the risk for cerebrovascular disease (CeVD), according to a study published in the...

Million Hearts Model Cuts Five-Year Heart Attack, Stroke Risk in At-Risk Patients

WEDNESDAY, Oct. 18, 2023 -- The Million Hearts Model, which encouraged and paid for cardiovascular disease (CVD) risk assessment and reduction, cut first-time heart attacks and...

Hypoattenuation Thickening on CT Prognostic After Left Atrial Appendage Occlusion

WEDNESDAY, Sept. 13, 2023 -- For patients with atrial fibrillation undergoing left atrial appendage occlusion (LAAO), high-grade hypoattenuation thickening (HAT) at follow-up...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.